|
MPST expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.899190E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.769200E-01 |
| Normal-vs-Stage2 |
5.941600E-02 |
| Normal-vs-Stage3 |
3.878000E-02 |
| Normal-vs-Stage4 |
1.459580E-02 |
| Stage1-vs-Stage2 |
1.912430E-01 |
| Stage1-vs-Stage3 |
7.275500E-02 |
| Stage1-vs-Stage4 |
5.696300E-02 |
| Stage2-vs-Stage3 |
9.525400E-01 |
| Stage2-vs-Stage4 |
3.005000E-01 |
| Stage3-vs-Stage4 |
2.377000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.494600E-01 |
| Normal-vs-AfricanAmerican |
2.321800E-01 |
| Normal-vs-Asian |
4.322400E-03 |
| Caucasian-vs-AfricanAmerican |
6.537400E-01 |
| Caucasian-vs-Asian |
2.415600E-02 |
| AfricanAmerican-vs-Asian |
7.957800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.394400E-01 |
| Normal-vs-Female |
1.065610E-02 |
| Male-vs-Female |
3.958900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.321900E-02 |
| Normal-vs-Extreme_Weight |
5.910400E-01 |
| Normal-vs-Obese |
1.785230E-01 |
| Normal-vs-Extreme_Obese |
5.589400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.455900E-02 |
| Normal_Weight-vs-Obese |
4.052600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.133000E-01 |
| Extreme_Weight-vs-Obese |
3.005600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.893600E-01 |
| Obese-vs-Extreme_Obese |
7.975000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.138000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.534400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.567000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.454000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.367400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.286800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.973600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.160400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.224600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.172000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.412800E-01 |
| Normal-VS-Type2 PRCC |
1.739610E-02 |
| Normal-VS-KIRP CIMP |
5.823100E-03 |
| Normal-VS-Unclassified PRCC |
2.799100E-03 |
| Type1 PRCC-VS-Type2 PRCC |
4.446100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.258000E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.5142000000008E-05 |
| Type2 PRCC-VS-KIRP CIMP |
1.858420E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.052600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.462600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.394400E-01 |
| Normal-vs-N1 |
1.112160E-02 |
| Normal-vs-N2 |
1.229410E-01 |
| N0-vs-N1 |
9.034300E-02 |
| N0-vs-N2 |
2.915600E-01 |
| N1-vs-N2 |
7.283400E-01 |
|
|
